Literature DB >> 35359162

Can we predict favourable quality of life after surgically treated vertebral osteomyelitis? Analysis of a prospective study.

A Yagdiran1, C Otto-Lambertz2, B Sondermann2, A Ernst3, D Jochimsen4, R Sobottke5, J Siewe6, P Eysel2, N Jung4.   

Abstract

PURPOSE: Vertebral osteomyelitis (VO) is a severe clinical entity associated with significant morbidity and mortality. Several studies have showed that successful treatment of VO patients leads to significantly improved quality of life (QoL). Nevertheless, QoL levels of these patients remained below those of the general population. There are rarely studies focusing on predicting factors for favourable QoL after surgically treated VO. The aim of this study was to identify factors influencing positively the QoL of patients undergoing surgery for VO.
METHODS: We conducted a prospective monocentric study including surgically treated VO patients from 2008 to 2016. Data were collected before (T0) and 1 year (T1) after surgery. Primary outcome was favourable QoL defined as back pain with disability restricting normal life activity with a cutoff value ≥ 12 on Oswestry Disability Index (ODI). ETHICS: Ethical approval was given by the Faculty of Medicine at the University of Cologne (09-182).
RESULTS: A total of 119 patients surviving 1 year after surgically treated VO were analysed. Favourable QoL was achieved in 35/119 patients. On multivariate analysis, younger age (hazard ratio = HR: 0.95; 95% CI 0.91-0.99; p = 0.022), lower albumin (HR: 0.9; 0.83-0.98; p = 0.019) an ASA score ≤ 2 (HR:4.24; 95%CI 1.42-12.68; p = 0.010), and a lower preoperative leg pain on the VAS (HR: 0.86; 95% CI 0.76-0.97; p = 0.018) were identified as independent risk factors for favourable QoL. Interestingly, the absence of neurological deficits was not predictive for a favourable outcome by means of QoL.
CONCLUSION: One-third of surgically treated VO patients (29%) in our cohort achieved favourable QoL by means of ODI. Our findings can facilitate an estimation of the prognosis when informing the patient before surgery, and underscore that spine disability questionnaires, such as ODI, measuring QoL, are mandatory to evaluate comprehensively the outcome of this entity.
© 2022. The Author(s).

Entities:  

Keywords:  Oswestry Disability Index (ODI); Patient-related outcome measures (PROMs); Predicting factors; Quality of life (QoL); Spondylodiscitis

Year:  2022        PMID: 35359162     DOI: 10.1007/s00402-022-04431-3

Source DB:  PubMed          Journal:  Arch Orthop Trauma Surg        ISSN: 0936-8051            Impact factor:   3.067


  19 in total

Review 1.  The Oswestry Disability Index.

Authors:  J C Fairbank; P B Pynsent
Journal:  Spine (Phila Pa 1976)       Date:  2000-11-15       Impact factor: 3.468

2.  Long-term functional outcome in pyogenic spinal infection.

Authors:  Brendan J O'Daly; Seamus F Morris; S Kieran O'Rourke
Journal:  Spine (Phila Pa 1976)       Date:  2008-04-15       Impact factor: 3.468

3.  Long-term mortality after Staphylococcus aureus spondylodiscitis: a Danish nationwide population-based cohort study.

Authors:  Theis Aagaard; Casper Roed; Anders R Larsen; Andreas Petersen; Benny Dahl; Peter Skinhøj; Niels Obel
Journal:  J Infect       Date:  2014-05-15       Impact factor: 6.072

4.  The normative score and the cut-off value of the Oswestry Disability Index (ODI).

Authors:  Juichi Tonosu; Katsushi Takeshita; Nobuhiro Hara; Ko Matsudaira; So Kato; Kazuhiro Masuda; Hirotaka Chikuda
Journal:  Eur Spine J       Date:  2012-08       Impact factor: 3.134

5.  Spondylodiscitis: Diagnosis and Treatment Options.

Authors:  Christian Herren; Norma Jung; Miguel Pishnamaz; Marianne Breuninger; Jan Siewe; Rolf Sobottke
Journal:  Dtsch Arztebl Int       Date:  2017-12-25       Impact factor: 5.594

6.  Multidisciplinary management of pyogenic spondylodiscitis: epidemiological and clinical features, prognostic factors and long-term outcomes in 207 patients.

Authors:  Enrico Pola; F Taccari; G Autore; F Giovannenze; V Pambianco; R Cauda; G Maccauro; M Fantoni
Journal:  Eur Spine J       Date:  2018-04-17       Impact factor: 3.134

7.  [Tuberculosis Guideline for Adults - Guideline for Diagnosis and Treatment of Tuberculosis including LTBI Testing and Treatment of the German Central Committee (DZK) and the German Respiratory Society (DGP)].

Authors:  Tom Schaberg; Torsten Bauer; Folke Brinkmann; Roland Diel; Cornelia Feiterna-Sperling; Walter Haas; Pia Hartmann; Barbara Hauer; Jan Heyckendorf; Christoph Lange; Albert Nienhaus; Ralf Otto-Knapp; Martin Priwitzer; Elvira Richter; Rudolf Rumetshofer; Karl Schenkel; Otto Dagobert Schoch; Nicolas Schönfeld; Ralf Stahlmann
Journal:  Pneumologie       Date:  2017-06-26

8.  Increased short- and long-term mortality among patients with infectious spondylodiscitis compared with a reference population.

Authors:  Michala Kehrer; Court Pedersen; Thøger Gorm Jensen; Jesper Hallas; Annmarie T Lassen
Journal:  Spine J       Date:  2015-02-19       Impact factor: 4.166

9.  Quality of life and mortality after surgical treatment for vertebral osteomyelitis (VO): a prospective study.

Authors:  Ayla Yagdiran; Norma Jung; Jan Siewe; Christina Otto-Lambertz; Kristina Michaela Lingscheid; Krishnan Sircar; Christina Samel; Max Joseph Scheyerer; Kourosh Zarghooni; Peer Eysel; Rolf Sobottke
Journal:  Eur Spine J       Date:  2020-07-01       Impact factor: 3.134

10.  Current diagnosis and treatment of spondylodiscitis.

Authors:  Rolf Sobottke; Harald Seifert; Gerd Fätkenheuer; Matthias Schmidt; Axel Gossmann; Peer Eysel
Journal:  Dtsch Arztebl Int       Date:  2008-03-07       Impact factor: 5.594

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.